Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOGEN INC. Director's Dealing 2024

Feb 20, 2024

30291_dirs_2024-02-20_540d2fe3-e9ad-4f30-ad60-ecdc6661a17f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOGEN INC. (BIIB)
CIK: 0000875045
Period of Report: 2024-02-15

Reporting Person: Rowinsky Eric K (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-02-15 Common Stock P 455 $222.54 Acquired 20629 Direct